作者
Serre-Yu Wong,Cathy Rowan,Elvira Diaz Brockmans,Cindy C Y Law,Elisabeth Giselbrecht,Celina Ang,Sergey Khaitov,David B. Sachar,Alexandros D Polydorides,Leon Shin‐han Winata,Bram Verstockt,Antonino Spinelli,David T. Rubin,Parakkal Deepak,Dermot P B McGovern,Benjamin D McDonald,Phillip Lung,Lilli Lundby,Amy L. Lightner,Stefan D Holubar,L Hanna,Carla Hamarth,J Geldof,Anders Dige,Benjamin L. Cohen,Michele Carvello,Cristiana Bonifacio,Gabriele Bislenghi,Corina Behrenbruch,David H. Ballard,Emre Altınmakas,Shaji Sebastian,Phil Tozer,Ailsa Hart,Jean–Frédéric Colombel
摘要
Perianal fistulizing Crohn's disease (PFCD)-associated anorectal and fistula cancers are rare but often devastating diagnoses. However, given the low incidence and consequent lack of data and clinical trials in the field, there is little to no guidance on screening and management of these cancers. To inform clinical practice, we developed consensus guidelines on PFCD-associated anorectal and fistula cancers by multidisciplinary experts from the international TOpClass consortium.